2019 Wyoming Statutes
Title 35 - Public Health and Safety
Chapter 4 - Health Regulations Generally
Article 9 - Emergency Administration of Opiate Antagonist Act
Section 35-4-902 - Definitions.
(a) As used in this article:
(i) "Opiate antagonist" means naloxone hydrochloride, narcan or any other brand name used for naloxone hydrochloride approved by the United States food and drug administration for the treatment of an opiate related drug overdose;
(ii) "Opiate related drug overdose" means a condition, including extreme physical illness, a decreased level of consciousness or respiratory depression resulting from the consumption or use of an opioid, or another substance with which an opioid was combined, that a reasonable person would believe to require medical assistance;
(iii) "Pharmacist" means any person licensed under Wyoming statutes as a pharmacist and who is practicing within the scope of their license;
(iv) "Practitioner" means any person licensed under Wyoming statutes as a physician, physician assistant or advanced practice registered nurse and who is practicing within the scope of their license;
(v) "Standing order" means an order transmitted electronically or in writing by a practitioner for a drug or device for a patient or multiple patients with whom no prescriber-patient relationship exists;
(vi) "Entity" means any person as defined in W.S. 8-1-102(a)(vi) who employs persons who, in the course of their official duties or business, may encounter a person experiencing an opioid related drug overdose;
(vii) "Opioid" means an opiumlike compound that binds to one (1) or more of the major opioid receptors in the body.